About KaroKidney
The Karolinska Kidney Research Network – KaroKidney – was initiated in 2010 as a joint research effort between the renal-, transplantation-, pediatric- and pathology departments at Karolinska University Hospital.
KaroKidney is a translational kidney research cluster based in Stockholm, Sweden. KaroKidney promotes programs for synergistic collaborations between basic and clinical researchers that will lead to discoveries and better healthcare strategies aimed at improving outcome for patients with kidney disease.
Biobank
KaroKidney's expanding biobank currently contains approximately 1500 renal biopsies (>740 native kidney biopsies from adult patients, 270 pediatric patients, 290 living donors and 180 transplanted patients) and >450 arterial biopsies from patients with ESRD and healthy controls. The tissue is stored in ways that allows analysis of both morphology and RNA/protein expression.
Patient representative
- Sven Jonsson
Patient representative. - Swedish Kidney Association
National patient organisation. Board member. - Swedish Kidney Association Stockholm Gotland
Regional patient organisation. Chair. - Medtech4Health
Board member. - Swedish Heart and Lung Association Stockholm
Patient organisation. Elected auditor. - LivAbility Nordic AB
CEO and Founder.
Collaboration
KaroKidney is a collaboration between researchers from Karolinska Institutet and Karolinska University Hospital.